Skip to Content
Browse all medications
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Advanced
Phonetic
Search:
Drugs A-Z
Complete A - Z Drug Index
Drugs by Condition
Drugs by Class
Drug Side Effects
Drug Dosage
Pregnancy Warnings
Breastfeeding Information
International Drugs
Generic Drugs
Veterinary Drugs
Natural Products
Phonetic Search
Harvard Health Topics
Medical Encyclopedia
Pill Identifier
Interactions Checker
News / Alerts
FDA Medwatch Drug Alerts
FDA Labeling Changes
Daily MedNews for Consumers
Pharmaceutical Industry News
Clinical Trial News
New Drug Approvals
New Drug Applications (Pipeline)
Get News via RSS
Get News via Twitter
Drugs.com Blog
Health Professionals
Professional Resource Center
FDA Prescribing Information
AHFS DI Monographs
A-Z Drug Facts for the Professional
Drug Interactions Checker
Patient CareNotes for the Professional
Natural Products Database
Medical Conferences
Pharmaceutical Company Directory
Medical Dictionary
Phonetic Drug Search
Community
Ask Medical Questions
Join Support Groups
Forum - Discussion Boards
Mednotes
Apps
Home
›
News
›
Pharma Industry News
› Archive
Pharmaceutical Industry News Archive
Get news
By email
or subscribe to our
News feeds
.
All News
Consumer
Pharma
New Drugs
Pipeline
Clinical Trials
May 2008
May 1
Sepracor to Acquire Oryx Pharmaceuticals Inc. and Expand Commercial Operations into Canada
Eisai Gained Favourable Ruling by Court of Appeal, as NICE Process for Developing Guidance on Anti-dementia Medicines Ruled Unfair
NUCRYST Announces Management Realignment and R&D Portfolio Change
Abbott, Takeda Conclude TAP Joint Venture
SEC Charges McCann-Erickson Worldwide With Accounting Fraud
Interpublic Announces Agreement to Settle SEC Claims
'Sharing Miracles' Television Program to Feature Leave it to Beaver Star Jerry Mathers
Renovis Stockholders Approve Acquisition by Evotec
May 2
Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals' Nicotinic Alpha-7 Agonist, MEM 3454
QSV Biologics Awarded cGMP Manufacturing Contract by Pfizer Inc.
Merck Extends Enrollment Deadline in Program to Resolve U.S. Vioxx Product Liability Lawsuits
Critical Therapeutics Signs Definitive Agreement to Merge with Cornerstone BioPharma
May 5
Nordic Capital Fund VII and Avista Capital Partners Agree to Acquire ConvaTec Business for approximately $4.1 Billion
Curis Announces Genentech's Initiation of Hedgehog Antagonist Phase II Clinical Trial In Metastatic Colorectal Cancer
VaxGen Sells Anthrax Vaccine Program and Related Assets and Technology to Emergent BioSolutions, Inc.
GE Healthcare Signs Global Molecular Diagnostic Agreement to Advance Respiratory Drug Development
May 6
Merck to Reduce U.S. Sales Force by 1,200 Positions
Bayer Schering Pharma to Market New Low-dose Oral Contraceptive Yaz in Europe
Teva Reports First Quarter 2008 Results
EPO Announces Symbicort European COPD Use Patent Decision
Fougera First-to-Market With Calcipotriene Topical Solution 0.005% (Rx) (Scalp Solution)
Stiefel Laboratories, Inc. Acquires ABR Invent and ABR Development
May 7
Enzon Pharmaceuticals, Inc. Announces Plan to Spin-off Biotechnology Business
ACT Biotech Acquires Clinical and Early Stage Oncology Portfolio Licenses From Bayer Healthcare
Quintiles Signs Agreement to Acquire Eidetics
May 8
King Pharmaceuticals Reports First-Quarter 2008 Financial Results
Biovail Announces New Strategic Focus
Novartis Exercises Rights to Purchase Additional Shares of Alnylam's Common Stock in Accordance with Terms of Existing Investor Rights Agreement
GAO Report: Prescription Drugs - Trends in FDA’s Oversight of Direct-to-Consumer Advertising
FDA Sends Letter to Shire Over Fosrenol Promotional Materials
FDA Sends Novartis Warning Letter Over Trileptal Promotional Materials.
May 9
Orion has decided not to continue the development of a new COMT inhibitor candidate
Schweizerhall: Impending Approval of Clopidogrel from Cimex in Germany
Takeda Sees Operating Profit Drop for 2nd Yr on Swelling Costs
Lancet: Combating Counterfeit Drugs
May 12
Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the Azor Co-Promotion Agreement
Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex
Walgreens Health Initiatives Reports Negative Drug Trend for Highly Managed Plans
May 13
Pharmexa Stops One of Two Phase III Trials
Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results
Daiichi Sankyo: Expansion of Business into Turkey and India
Lilly Partners With TopCoder, to Find Drug Discovery IT Solutions
Higher Risk of Death and Stroke in Patients Given Beta-Blockers After Non-Cardiac Surgery (POISE Trial)
Bristol-Myers Squibb and KAI Pharmaceuticals Enter Global Alliance to Develop and Commercialize KAI-9803 for Cardiovascular Disease
Angiotech appoints Hank McKinnell to its Board of Directors
Lilly Backs Federal Legislation to Inform the Public on Payments to Physicians
May 14
Chronic Medication Nation: Research Finds Chronic Health Problems Now Afflict More Than Half of All Americans
Takeda Completes Subsequent Offering Period for Shares of Millennium Pharmaceuticals, Inc.
Securities Class Action Against Discovery Labs is Dismissed
Sosei Announces Outcome of Strategy Review
Mylan Launches Paroxetine Hydrochloride Extended-Release Tablets
Takeda Completes Acquisition of Millennium
FDA Places Geron's GRNOPC1 IND on Clinical Hold
FDA releases a Follow-up to the November 14, 2007, Communication about the Ongoing Safety Review of Cefepime (marketed as Maxipime)
Merck Wins Appeal in Vioxx Case
May 15
Manufacturer Removes Remaining Stocks of Trasylol
IMS Health Forecasts Continued Double-Digit Annual Growth of Cancer Therapeutics: Global Sales Expected to Exceed $75 Billion by 2012
Diabetes Drugs Emerge as Top Force in Drug Spending Growth
Biovitrum AB (SE) - Biovitrum Implements Strategic Restructuring of the R&D Organization
Forbes Medi-Tech Announces Corporate Restructuring --Company To Focus Exclusively on Core Nutraceutical Business and Reduce 2008 Research and Development Expenses by Approximately $2.7 Million-
Ortho Biotech, L.P. and Centocor, Inc. Alert Authorized Distributors and Prescribing Physicians About Stolen Product
District Court Decision Affirmed in U.S. Lovenox (enoxaparin sodium) Patent Infringement Case
May 16
American Red Cross Vindicated in J&J Lawsuit
Statement - New CIHI Report shows value of new medicines in health care system, Rx&D
Antisoma plc (UK) - Antisoma to Acquire Boston-Based Xanthus Pharmaceuticals
Celebrex Shows Benefit In First-of-Its-Kind Lung Cancer Chemoprevention Trial
Biovail Subsidiary Reaches Settlement with United States Department of Justice
Information on Mycophenolate Mofetil (marketed as CellCept) and Mycophenolic Acid (marketed as Myfortic)
May 19
Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
Ipsen and Medicis Announce Acceptance of Reloxin BLA in Aesthetics by FDA
Biogen Idec Celebrates 30 Years of Transforming Discovery into Care
Customs: Commission Publishes 2007 Customs Seizures of Counterfeit Goods at the EU's External Border
May 20
Record Venture Capital and Heated Deal Environment Propel Global Biotechnology Industry Forward in 2007
Global Menopause Summit Concludes HRT is Safe for Healthy Women Entering Menopause
FivePrime and Pfizer Enter Oncology and Diabetes Collaboration
May 21
Daiichi Sankyo Co., Ltd. Announces Acquisition of Biotech Firm U3 Pharma AG
ACHIEVE Imaging Study Discontinued
Reps. Dingell, Stupak Request Improved Accuracy, Stronger Guidelines for DTC Ads
Lilly Announces Changes in Key Leadership Roles
May 22
FTC’s Bureau of Competition Issues FY 2007 Summary of Pharmaceutical Company Settlement Agreements
Amgen Posts Medical Education and Foundation Grants and Donations as Part of the Company's 'Clearly Amgen' Initiative
ThalesNano Inc. and sanofi-aventis R&D Collaborate on Continuous Process Chemistry in Order to Dramatically Reduce Drug Realization Time
AstraZeneca Supports Transparency Legislation on Payments to Health Care Providers
eHealth Initiative's Drug Safety Collaboration to Partner With FDA on Sentinel Initiative
New Efforts to Help Improve Medical Products for Patient Safety and Quality of Medical Care
May 27
Migenix Takes Operational Actions To Extend Cash Past Upcoming Key Milestones
Alnylam and Takeda Form Strategic Worldwide Platform Alliance in RNAi Therapeutics
Santarus Achieves $2.5 Million Regulatory Milestone under OTC License Agreement with Schering-Plough
Short-Term Use of Antipsychotics in Older Adults with Dementia Linked to Serious Adverse Events
May 28
Taro Terminates Merger Agreement with Sun Pharmaceutical Industries Ltd.
Statement on Third-party Clopidogrel Applications in Germany
Pfizer Names Amy W. Schulman as Senior Vice President and General Counsel
Westaim Updates Shareholders on Strategic Alternatives
Boston Scientific Announces Court Decision
Pharma Companies Integrate Customer Service Portals for Physicians into the Marketing Mix
Australian Full Federal Court Upholds Basic Lipitor Patent, Preventing Launch of Generic Ranbaxy Product
Schweizerhall: Clopidogrel From Cimex Approved in Germany
May 29
Favrille Announces Workforce Reduction
Sun Pharma responds to Taro's purported termination of merger agreement
Bristol-Myers Squibb to Acquire Kosan Biosciences
Merck Wins Appeal of First Vioxx Case to Go to Trial
Merck Wins Appeal of First Vioxx Case to go to Trial
Cardiovascular Meds May Be Beneficial in Alzheimer's Disease, According to MedPredict Report
Assembly on the Move for Rx Reform
The Lanier Law Firm Will Appeal Court Reversal of Jury Award to Widow in Nation's 1st Vioxx Trial
May 30
Gilead and Navitas Announce Agreement for Cicletanine for the Treatment of Pulmonary Arterial Hypertension
Bristol-Myers Squibb Reaffirms 2008 Earnings Guidance
Pharmacopeia Advances Strategic Plan to Focus Resources on Development and Later-Stage Discovery Programs
Pharmaceutical Industry News Archive
2012
January
,
February
2011
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2010
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2009
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2008
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2007
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2006
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2005
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2004
January
,
February
,
March
,
April
,
May
,
July
,
August
,
September
,
October
,
November
,
December
2003
January
,
February
,
March
,
April
,
May
,
June
,
July
,
August
,
September
,
October
,
November
,
December
2002
January
,
April
,
May
,
June
,
August
,
September
,
October
,
November
,
December
More News Resources
FDA Medwatch Drug Alerts
FDA Drug Safety Labeling Changes
Daily MedNews
Pharma Industry News
New Drug Approvals
New Drug Applications
Clinical Trial Results
Generic Drug Approvals
Monthly Update Archive
Printable Version
Email
Recommend
Tweet
Save or Share
Search:
Sign In
or
Register
Username
Password
Forgot password?
FDA Consumer Updates
Primatene Mist With Chlorofluorocarbons No Longer Available After Dec. 31, 2011
HCG Diet Products are Illegal
Lock it Up: Medicine Safety in Your Home
Reducing Fever in Children: Safe Use of Acetaminophen
More FDA Updates...
Recently Approved
Mitosol
Mitosol (mitomycin) is an antimetabolite indicated as an adjunct to ab externo glaucoma surgery.
Sklice
Sklice (ivermectin) Lotion is a pediculicide indicated for the topical treatment of head lice infestations in ...
Jentadueto
Jentadueto (linagliptin and metformin) is a dipeptidyl peptidase-4 (DPP-4) inhibitor and biguanide ...
Kalydeco
Kalydeco (ivacaftor) is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator indicated ...
Erivedge
Erivedge (vismodegib) is a hedgehog pathway inhibitor for the treatment of patients with advanced basal cell ...
More...
Get Updates by Email
Email me:
FDA Medwatch Alerts
News Roundup
Daily
Weekly
Monthly
Email
(web3)